Future Outcome of Sonography BI-RADS Category 3 Lesions

Author(s):
Afsaneh AlikhassiAfsaneh AlikhassiAfsaneh Alikhassi ORCID1,*
1Tehran University of Medical Sciences, Tehran, Iran

IJ Radiology:Vol. 14, issue Special Issue; e47968
Published online:Apr 12, 2017
Article type:Abstract
Received:Dec 20, 2016
Accepted:Feb 07, 2017
How to Cite:Alikhassi A. Future Outcome of Sonography BI-RADS Category 3 Lesions. I J Radiol. 2017;14(Special Issue):e47968. doi: https://doi.org/10.5812/iranjradiol.47968

Abstract

Objectives:

This study aims to find the frequency and the malignancy rate of BI-RADS category 3 lesions detected on screening breast ultrasound and to evaluate whether they fullfilled the requirements of the latest American college of radiology imaging and reporting system.

Methods:

Of 500 asymptomatic women who came to our center for screening sonography themselves or referred by their clinician, patients for whom BI-RADS category 3 lesions were seen on the ultrasound were selected. Clinical outcome of these lesions using one year follow up, biopsy or a combination of both were evaluated.

Results:

The frequency of BI-RADS category 3 lesions detected on screening ultrasound was 18% (90/500). Of these patients, one was eventually proven to have malignancy with malignancy rate of 1.1%. This detected malignancy was early breast cancer with no lymph node metastasis.

Conclusions:

Although the frequency of ultrasound BI-RADS category 3 lesions is considerably high (18 %), the malignancy rate is low (1.1%). Therefore careful assessment and follow up of BI-RADS category 3 can avoid unnecessary biopsy or surgery.

Full Text

Full text is available in PDF

Similar Articles

30
Aug
2013

Interobserver and Intraobserver Agreement of Sonographic BIRADS Lexicon in the Assessment of Breast Masses

Eda Elverici,
Betul Zengin,
Ayse Nurdan Barca,
Pinar Didem Yilmaz,
Aysegul Alimli,
Levent Araz

Elverici E, Zengin B, Nurdan Barca A, Didem Yilmaz P, Alimli A, et al. Interobserver and Intraobserver Agreement of Sonographic BIRADS Lexicon in the Assessment of Breast Masses. I J Radiol. 2013;10(3):122-127. doi: https://doi.org/10.5812/iranjradiol.10708

30
Mar
2011

Screening Mammography for Breast Cancer in Women Using Bi‐RADS Scores

MM Tariq,
S Khubaib,
AB Imran,
Muhammad Ibrahim

Tariq M, Khubaib S, Imran A, Ibrahim M. Screening Mammography for Breast Cancer in Women Using Bi‐RADS Scores. Int J Cancer Manag. 2011;4(1):e80723. doi:

10
Mar
2018
Evaluation of Suspicious Appearing Microcalcification Groups on Mammogram: Comparing BI-RADS 5th Edition Descriptors with the BI-RADS 4th Edition and Pathologic Association

Evaluation of Suspicious Appearing Microcalcification Groups on Mammogram: Comparing BI-RADS 5th Edition Descriptors with the BI-RADS 4th Edition and Pathologic Association

Nasrin Ahmadinejad,
Maryam Jafari,
Maryam Rahmani,
Kiara Rezaei-Kalantari,
Madjid Shakiba

Ahmadinejad N, Jafari M, Rahmani M, Rezaei-Kalantari K, Shakiba M. Evaluation of Suspicious Appearing Microcalcification Groups on Mammogram: Comparing BI-RADS 5th Edition Descriptors with the BI-RADS 4th Edition and Pathologic Association. I J Radiol. 2018;15(2):e14013. doi: https://doi.org/10.5812/iranjradiol.14013

12
Apr
2017

Is There Any Correlation Between MRI Features of Breast Lesions of BI-RADs Category 4 with Histopathologic Results?

Ghazaleh Jamalipour Soufi

Jamalipour Soufi G. Is There Any Correlation Between MRI Features of Breast Lesions of BI-RADs Category 4 with Histopathologic Results?. I J Radiol. 2017;14(Special Issue):e48045. doi: https://doi.org/10.5812/iranjradiol.48045

2
May
2022
Iran J Radiol

Underestimation of Breast Cancer Based on Ultrasound Breast Imaging-Reporting and Data System (BI-RADS) Assessment of Ductal Carcinoma In Situ: A Retrospective Study of 296 Lesions

Jing Yao,
Li Chen,
Danru Liu,
Lina Fu,
Yong Wang,
Limin Chen

Yao J, Chen L, Liu D, Fu L, Wang Y, et al. Underestimation of Breast Cancer Based on Ultrasound Breast Imaging-Reporting and Data System (BI-RADS) Assessment of Ductal Carcinoma In Situ: A Retrospective Study of 296 Lesions. I J Radiol. 2022;19(1):e114808. doi: https://doi.org/10.5812/iranjradiol-114808


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC